Andres Ricaurte Fajardo on CVT Experience from a Latin American Cohort
Andres Ricaurte Fajardo, Neurology resident at Pontificia Universidad Javeriana, shared on LinkedIn:
”Proud to share our latest article in the Journal of Stroke and Cerebrovascular Diseases:
“Clinical characterization and predictors of poor outcome in patients with cerebral venous thrombosis: Experience from a Latin American cohort.”
This study, conducted at Hospital Universitario San Ignacio (Bogotá, Colombia), provides one of the largest Latin American datasets of cerebral venous thrombosis (CVT) to date — highlighting regional risk patterns, imaging features, and outcome predictors in a high-altitude, low- and middle-income setting.
Key take-home messages
1. Headache remains the hallmark presentation — often mimicking migraine — emphasizing the need for high clinical suspicion even in isolated headache cases.
2. Anemia emerged as an independent predictor of poor in-hospital outcome, underscoring the role of systemic factors in CVT prognosis.
3. Venous infarction and subarachnoid hemorrhage were strong radiological predictors of poor functional recovery.
4. The CVT Risk Score showed external validity in this Latin American cohort, supporting its use for bedside triage.
5. These findings advocate for context-adapted risk stratification and management strategies tailored to LMIC environments.
6. Active malignancy was present in 12% of cases — reinforcing the intersection between cancer and cerebral thrombosis, a relationship increasingly recognized in neuro-oncology and systemic disease.
Grateful to my amazing co-authors and mentors from Pontificia Universidad Javeriana for this collaborative effort toward advancing stroke research in Latin America.”
Read the full article here.
Article: Clinical characterization and predictors of poor outcome in patients with cerebral venous thrombosis: Experience from a Latin American cohort
Authors: Andres Felipe Cardenas-Cruz, Andres Ricaurte-Fajardo, Silvia Andrade, Carlos Alvarado-De la Hoz, Isabel Torres-Camacho, Elkin Garcia-Cifuentes, Maria Paula Ardila, Betty Arevalo, Carlos Beltran, Laura Monsalve, Luis Roa-Wandurraga, Juliana Coral-Casas
Stay updated on all scientific advances in the field of thrombosis with Hemostasis Today.
-
Jul 4, 2026, 17:38Michael Stark: Greater Improvements in Cerebral Oxygenation With Restrictive Transfusion Thresholds
-
Jul 4, 2026, 17:27Reza Shojaei: How America Won the Plasma Race
-
Jul 4, 2026, 17:26Akshat Jain: The First CRISPR-Cas9 Gene Therapy Approved for Children as Young as 2 with SCD
-
Jul 4, 2026, 17:25Francesca Palandri: Dynamic, Treatment Response-Driven Risk Assessment in Polycythemia Vera
-
Jul 4, 2026, 17:24Thierry Burnouf: The Fragile Supply of Human Hyperimmune Immunoglobulins
-
Jul 4, 2026, 15:41Emmanuel J. Favaloro: New Research Highlights Benchmarks for Low Molecular Weight Heparin Monitoring
-
Jul 4, 2026, 15:38Roshni Kulkarni: Maternal Mortality In Bleeding Disorders
-
Jul 4, 2026, 15:34Alejandro González Veliz: Does Elevated Lp(a) Always Mean the Same Cardiovascular Risk?
-
Jul 4, 2026, 15:20Bruno Pougault: Heparin Monitoring Remains One of the Most Challenging Areas in Laboratory Hemostasis